Why the study?
Diabetes plays an important role in the complex relationship between chronic kidney disease and cardiovascular disease, but the influence of eGFR and proteinuria on MACE risk across diabetes status needed comparison.
Population
CKD patients without prior MACE classified as T1DM (n = 164), T2DM (n = 9,711), and non-DM (n = 75,789)
Comparison
eGFR and proteinuria categories in CKD patients with vs without diabetes
Design
Retrospective observational study
Authors
Loading...
Diabetes amplifies MACE risk at equivalent eGFR in CKD; extends observational data on independent predictors but leaves practice change open.
In patients with CKD, reduced eGFR and proteinuria independently increase MACE risk, but this risk is substantially amplified in the presence of type 2 diabetes.
Currie et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: